| Date | Title | Description |
| - | Heliocentris receives additional order from Myanmar worth EUR 3m | Berlin, August 26, 2014 --- Heliocentris Energy Solutions AG, a leader in solutions and services for energy efficiency and distributed power systems, announced today that it has received a further purchase order to deliver and install compl... |
| - | Realeyes partners with MediaCom | We’re very pleased to announce the launch of our global partnership with MediaCom, who will be incorporating Realeyes’ emotional intelligence into their creative testing and media planning processes.
Marketing Week describes it as a 'landma... |
| - | Xeros acquires MarKen PPE Restoration | Xeros Technology Group plc (AIM: XSG, 'Xeros', 'the Group'), the developer and provider of polymer based technologies with multiple commercial applications, has agreed to acquire MarKen PPE Restoration ('MarKen'), which provides personal pr... |
| - | NewMotion acquired by Shell | Amsterdam, Oct 12, 2017 – Shell, one of the world’s largest energy providers, has signed an agreement to buy NewMotion in a deal that will enable both companies to accelerate the transition to low-carbon transport. |
| - | Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | PSX1002 is a novel formulation of glycopyrronium bromide (GB), a long-acting muscarinic antagonist (LAMA), that is being developed as a potential ‘best-in-class’ orally inhaled monotherapy for COPD. PSX1002 was designed using Prosonix’ prop... |
| - | Evolva concludes licensing of EV-077 to Serodus | The successful divestment enables further development of EV-077 to address unmet patient needs by an experienced and committed team. It is fully in line with Evolva's shift away from pharma and towards ingredients for health, wellness and n... |
| - | Entrepreneurs Fund Exits Evolva | - |
| - | Study shows LifePort® helps improve kidney transplant patient outcomes | Lifeline Scientific (AIM: LSIC), the transplantation technology company, welcomes the publication in Experimental and Clinical Transplantation of the clinical study (‘Study’): “Hypothermic Machine Perfusion Permits Extended Cold Ischemia Ti... |
| - | Physicist’s Fusion Energy TED Talk Attracts One Million Viewers | Burnaby, BC – August 8, 2016 – A physicist’s TED talk on the potential of fusion energy has now been viewed by more than a million people. |
| - | Tom Gibbs Joins OptiNose™ as Chief Commercial Officer | October 7, 2016
Gibbs previously served as Senior Vice President, Head of General Medicines at Takeda Pharmaceuticals for the US Business Unit
Gibbs brings diverse background and proven track record to lead the launch of its next product, E... |
| - | Heliocentris achieves record sales in 2014 | Berlin, 4 February 2015 – Heliocentris Energy Solutions AG (ISIN DE000A1MMHE3) has achieved its sales guidance of €19-21 million for the 2014 financial year after a strong fourth quarter. Provisional calculations show that the leading provi... |
| - | FutureE receives Innovation Award | Berlin/Stuttgart, 16 December 2014 - Beginning of December the German fuel cell specialist FutureE Fuel Cell Solutions GmbH (WKN A1MMHE), which was acquired by Heliocentris Energy Solutions AG in June this year, has been awarded for their o... |
| - | Change to the Supervisory Board of Heliocentris | Change to the Supervisory Board of Heliocentris Energy Solutions AG
- Oliver Borrmann stepping down from the Supervisory Board after the Annual General Meeting
- Bernd Brunke proposed as new Supervisory Board member and Chairman of the Boar... |
| - | The New Motion welcomes AutoBinck as new shareholder | Sep 14, 2015 -- The New Motion, European market leader in offering charging solution for electric vehicles, welcomes AutoBinck as their new shareholder. The New Motion’s existing shareholders and founders will also contribute to the investm... |
| - | World first: Sequana's Pleurapump implanted to manage pleural effusions | Sequana Medical AG, a private Swiss medical device company with innovative fluid management technologies, today announced a world-first, as a patient at Hôpital Nord, Marseille, France, was implanted with a pleurapump system designed to man... |
| - | Marijn de Jong joins The New Motion as CFO | AMSTERDAM, The Netherlands - (November 3rd, 2014) - The New Motion, provider of charging solution for electric vehicles, has appointed Mr. de Jong as Chief Financial Officer. Mr. de Jong joined The New Motion in October and will focus on fa... |
| - | Evolva to participate in European research project | The project has a duration of four years and a total EU funding of EUR 7.2 million (CHF 8.9 million), of which Evolva’s share is 9.8%. The project is the latest of a series of EU collaborations that Evolva has been awarded with partners. |
| - | Exosect submit additional active ingredient to EU regulators | Jan 14th, 2015 -- Winchester, UK – Exosect Ltd, a leading provider of enabling technologies, today announced its submission of an Aluminium silicate (Kaolin) dossier to EU regulators as an additional active ingredient in support of its biop... |
| - | Lifeline Scientific trading update | Lifeline Scientific (AIM: LSIC), the transplantation technology company, provides the following trading update for the year ended 31 December 2014. |
| - | Nathan Gilliland joins General Fusion as CEO | Mr. Gilliland has an impressive track record in helping new businesses with bold objectives, an apt description of General Fusion. The firm, established in 2002 by physicist Dr. Michel Laberge, is a leader in the development of magnetized t... |
| - | Exosect signs first formulation out-licence deal | 13th March 2017
Winchester, UK – Exosect Ltd., a pioneer in Lean Formulation Technology®, today announced that it has signed its first commercial agreement with a leading agrochemical company. The formulation, uses Exosect’s proprietary for... |
| - | OptiNose Closes New Round of Financing | YARDLEY, PA, October 6, 2015— OptiNose a specialty biopharmaceutical company, announced today that it has closed a new round of financing providing up to $30M in additional capital. Since completing its previous financing round in August, 2... |
| - | Heliocentris admitted to the Prime Standard | Berlin, 12 May 2015 - Heliocentris Energy Solutions AG (ISIN DE000A1MMHE3) has today been admitted to the Prime Standard in the Regulated Market of the Frankfurt Stock Exchange by the Executive Board of the Frankfurt Stock Exchange. Helioce... |
| - | Heliocentris announces unaudited figures for 2015 | Heliocentris Energy Solutions AG announces unaudited figures for 2015 and a package of measures for sustainable profitable growth
- Sales growth in 2015: sales up 17% at EUR 22.1 million despite delayed incoming orders
- Forecast for 2016: ... |
| - | vasopharm Appoints Chief Medical Officer | Würzburg, Germany – November 8, 2016 – vasopharm GmbH, a privately held biopharmaceutical company focusing on novel therapeutics for the treatment of cerebrovascular diseases, today announced the appointment of Dr Irina Antonijevic as Chief... |
| - | Exosect receives US patent for Entomag | June 25th, 2013 -- Winchester, UK – Exosect, a leading provider of enabling technologies has announced that it has received a US patent for its Entomag delivery platform bringing the total number of patents granted for this technology to se... |
| - | OptiNose Announces FDA Acceptance for Filing of the New Drug Application for OPN-375 | YARDLEY, PA, January 31, 2017 – OptiNose™ today announced the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for the investigational new product OPN-375. OptiNose is seeking marketin... |
| - | General Fusion Closes USD$65 million of Series E Financing | VANCOUVER, Canada – General Fusion announced that it has successfully closed USD$65 million of Series E equity financing. The financing was led by Temasek, a global investment company headquartered in Singapore |
| - | Lifeline Scientific receives regulatory approval in China | Lifeline Scientific (AIM: LSIC), the transplantation technology company, announces that it has received long awaited regulatory approval for its LifePort Kidney Transporter (LifePort) for commercial sale in China and provides a trading upda... |
| - | Sequana Announces Results of alfapump® Multicentre, Post-Marketing Surveillance Registry | Zurich, SWITZERLAND 4 October 2017 -- Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the publication of “Treatment of refractory ascites with an... |
| - | General Fusion awarded $12.75M from SDTC | General Fusion Awarded $12.75 Million From Sustainable Development Technology Canada
BURNABY, BRITISH COLUMBIA – ( March 4, 2016) – Innovative cleantech company General Fusion has been awarded $12.75 million by Sustainable Development Techn... |
| - | Exosect partners with Bill & Melinda Gates Foundation | Jan 25th, 2013 -- Protecting maize from post-harvest pests - In Sub-Saharan Africa, most of the losses in the food supply chain take place during post-harvest storage and handling. |
| - | Xeros technology used in 4 out world's top 5 hotel groups | Xeros Technology Group plc (AIM: XSG), the innovative developer of a patented polymer bead cleaning system with multiple identified commercial applications is pleased to announce that, following its latest cleaning system contract win, it n... |
| - | OptiNose Raises $37 Million in Series D Funding Led by Fidelity | YARDLEY, PA, May 9, 2017 – OptiNose, a commercial-stage ENT / Allergy specialty pharmaceutical company, today announced that it has closed a $37 million Series D financing led by Fidelity Management and Research Company with participation f... |
| - | Xeros successfully completes £10 million funding round | Invesco Perpetual managed funds led the round, investing £6 million in Xeros. Shares in Xeros will be held in the Invesco Perpetual High Income Fund and the Invesco Perpetual Income Fund, which are managed by Neil Woodford, Head of UK Equit... |
| - | Heliocentris receives first volume purchase order from leading power components OEM | Berlin, November 5, 2014 - Heliocentris Energy Solutions AG, a leading provider of hybrid energy supply solutions has received a €1 million purchase order for its innovative Energy Management Systems from a world leader in the design and ma... |
| - | Henri Lloyd slashes garment returns rates | October 23rd 2013, London, UK – Customers that use Henri Lloyd’s virtual fitting room to check the fit of garments before they complete checkout have a garment returns rate – for any reason – of just 4.5%, compared to a returns rate of 15.3... |
| - | General Fusion Crowdsources Engineering Challenge | VANCOUVER, British Columbia—(April 22, 2015)— A Vancouver area high-tech energy company is now crowdsourcing some of its tough engineering and science challenges. |
| - | Heliocentris reports considerable growth in Q1 | Berlin, 29 May 2015 - Heliocentris Energy Solutions AG which is listed in the Prime Standard of the Frankfurt Stock Exchange (ISIN DE000A1MMHE3), is publishing its figures for the first quarter of 2015 today. In the first quarter of the cur... |
| - | Chinese Academy of Engineering Physics hosts General Fusion for a Bilateral Workshop on Fusion Energy | The Chinese Academy of Engineering Physics (CAEP) invited General Fusion to attend a two day bilateral fusion energy workshop in Mianyang, China. CAEP is home to several Chinese research projects on fusion energy; including magnetized targe... |
| - | Lifeline Scientific final results for 2014 | Lifeline Scientific (AIM: LSIC), the transplantation technology company, announces results for the year ended 31 December 2014, a strong year of growth with revenues and operating profits ahead of previous market expectations. The installed... |
| - | Prosonix announces Marketing Authorisation Application for PSX1001 in EU | OXFORD, UK, 1 September 2014 – Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that its Marketing Authorisation Application (MAA) for PSX1001 has been va... |
| - | Virtual fitting room provider Fits.me takes £5m in Series A funding | Previously, in May 2009 and August 2010, the company received total seed and early-stage investment of just under £1.75m from Smartcap and angel investors, and £0.5m in grants. |
| - | General Fusion forms new research Partnerships | BURNABY, British Columbia—(July 11, 2014)— A University of Saskatchewan research team led by physicist Akira Hirose is partnering with General Fusion to help develop advanced materials for their prototype fusion reactor technology... |
| - | The New Motion wins Green Deal Award | The winner of the Green Deal Award 2014 is the Green Deal “Charging infrastructure for Electric Mobility” set up by The New Motion. This was announced during the yearly Green Deal network event, which took place on November 24th. The New Mo... |
| - | Entrepreneurs Fund invests in SmartKem | Manchester and Wales, UK, (12 August, 2014). SmartKem, the leading developer of high performance, organic semiconductor materials for truly flexible displays and electronics, has announced the completion of a significant series A funding ro... |
| - | Major shipment to UAE | Xeros Technology Group plc (AIM:XSG, 'the Group', 'Xeros'), the UK-headquartered technology business and innovator of a near-waterless laundry system, announces the supply of 32 near-waterless washing machines to Encom Trading LLC, a wholly... |
| - | vasopharm provides update on Phase III TBI trial | March 12, 2018 - vasopharm GmbH, a privately held biopharmaceutical company, today announced that it has recruited half of the 220 patients in the ongoing, pivotal European NOSTRA III (NO Synthase in TRAumatic Brain Injury) clinical trial. ... |
| - | Optinose IPO | Yardley, PA, Oct. 12, 2017 — OptiNose, Inc. (Optinose), a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists, today announ... |
| - | Sequana Medical Announces IPO | Ghent, BELGIUM – November 8, 2018 – Sequana Medical NV (“Sequana Medical”, the “Company”), a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart fai... |
| - | Licensing agreement with leading Asian OEM | Xeros Technology Group plc has signed a binding Heads of Terms agreement ('agreement') with Ramsons Garment Finishing Equipment PVT Ltd ('Ramsons').Under the agreement, Ramsons will develop, manufacture and sell garment finishing equipment ... |
| - | D3O's CEO featured in Telegraph | Dec 31, 2014 -- Stuart Sawyer, CEO of D3O, is named among most disruptive entrepreneurs in Britain according to the Telegraph. The Telegraph also featured D3O's technology earlier in the year in an article titled "Real-life 'Flubber', ... |
| - | The New Motion 10,000th intelligent charging point opened | Download full article (in Dutch) |
| - | CYTOO selected by DAIICHI SANKYO | October 28th, 2015, Grenoble, France- CYTOO announces today that Daiichi Sankyo Company Limited, a Japanese pharmaceutical manufacturer with global presence, has selected CYTOO in vitro muscle platform MyoScreen™ to develop a novel cell-bas... |
| - | Evolva reports financial results for 2012 | Key highlights of 2012 and early 2013: |
| - | OptiNose Announces FDA Acceptance of New Drug Application for AVP-825 for the Acute Treatment of Migraine | As previously reported, the 505(b)(2) NDA for AVP-825 includes clinical data developed by OptiNose including a pivotal phase III controlled clinical trial, a supportive phase II controlled clinical trial and two pharmacokinetic studies. The... |
| - | 20/10 PERFECT VISION AG Completes Sale of Technolas Perfect Vision Leading ophthalmology laser maker acquired by Bausch + Lomb | Technolas Perfect Vision was established in 2009 through a joint venture between Bausch + Lomb and 20/10 PERFECT VISION AG to develop and sell advanced refractive and cataract technologies. The combination of Bausch + Lomb and Technolas Per... |
| - | SmartKem, Inc. Raises $24.6 Million | February 24, 2021. SmartKem, Inc. announced the closing of a $24.6 million private placement financing. Prior to the financing, SmartKem Limited (SmartKem) completed a reverse acquisition transaction with Parasol Investments Corporation (Pa... |
| - | Heliocentris: convertible bond extended to 2019 | Heliocentris Energy Solutions AG: Extension of the convertible bond provides additional planning security for further growth:
- Holders of the 2014/2017 convertible bond resolve upon the extension of the maturity date by two years to Januar... |
| - | Prosonix Reports Positive Top-line Results from its Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease | Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with PSX1002 in patients with moderate to sever... |
| - | General Fusion is Named in the 2014 Global Cleantech 100 | BURNABY, British Columbia—(October 6, 2014)— General Fusion, the Canadian company developing fusion power technology, today announced it was named in the prestigious 2014 Global Cleantech 100, produced by Cleantech Group. |
| - | SmartKem Presents at Display Week 2014 | San Diego, CA (23 May, 2014) – SmartKem Ltd, the leading developer of high performance, organic semiconductor materials for truly flexible displays and printed electronics, is to present its latest advances for organic semiconductor materia... |
| - | First Customer Win for Federal-Mogul Powertrain's New Product Group Controlled Power Technologies | SOUTHFIELD, Mich., March 28, 2018 /PRNewswire/ -- Federal-Mogul Powertrain today announced the first commercial customer contract for its new product group Controlled Power Technologies (CPT). The long-term contract, worth around $100m, cov... |
| - | OptiNose presents phase-III data from Chronic Rhinosinusitis study | September 16, 2016
Data from two Phase 3 trials were presented for the first time today at the American Rhinologic Society’s Annual Meeting
Data show significant improvement in both subjective symptoms and objective signs of disease with us... |
| - | Xeros scoops two major awards | Polymer bead-cleaning pioneer Xeros has won two prestigious awards, on different sides of the Atlantic in a single evening. The company won Bronze in the Energy/Sustainability category for its virtually waterless commercial laundry system a... |
| - | BASF and Cytoo join forces | January 21, 2016, Grenoble, France – BASF and the French biotechnology company CYTOO join forces. The goal of the partnership is to develop and test active ingredients that contribute to increase skin firmness in skin care applications.
Rec... |
| - | New CFO at Sequana Medical AG | Zurich, SWITZERLAND – 11 July 2016 – Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems that manage fluid build-up occurring in patients with ... |
| - | D3O recognised by Fast Track | 12. Sep 2016. D3O, the UK-based impact protection company, has been recognised by leading research and events company, Fast Track, as one of ten “Ones to Watch” in technology for 2016 in the annual Sunday Times Hiscox Tech Track 100. |
| - | SmartKem Collaborates with Centre for Process Innovation | Wales and Manchester, UK (19th February 2015): SmartKem, supplier of the market-leading tru-FLEX semiconductor platform, has announced an extensive collaboration programme with the Centre for Process Innovation (CPI), for the development o... |
| - | General Fusion Hosts Top Experts in Fusion Energy Research | VANCOUVER, CANADA – An annual gathering focusing on cutting-edge fusion energy research is being held outside the U.S. for the first time, with Vancouver-based clean energy leader General Fusion hosting the event from August 1-4.
The Explor... |
| - | Heliocentris announces commercial deal with Etisalat | Berlin, April 9, 2015 – On April 6, 2015, Heliocentris Energy Solutions AG (ISIN DE000A1MMHE3), a leading technology provider of hybrid power supply solutions, received a first order for the turnkey retrofit and hybridization of 30 base sta... |
| - | Evolva announces collaboration with L’Oréal | This collaboration will begin immediately and conclude in late 2016, and includes an option to expand the ingredient focus. L’Oréal will pay Evolva research fees during the project period. Additionally, Evolva is eligible to receive milesto... |
| - | Lifeline Scientific receives regulatory approval in China | Lifeline Scientific (AIM: LSIC), the transplantation technology company, announces that the Chinese Food and Drug Administration (CFDA) have formally approved the Company’s market leading clinical organ preservation and flush solutions, SPS... |
| - | Lifeline Scientific, Inc. announces merger with Shanghai Genext Medical Technology Co. | Lifeline Scientific, Inc. (AIM: LSIC), a leading international provider of clinical products and services in the field of transplantation, announces it has entered into a definitive merger agreement (the “Merger Agreement”) with Shanghai Ge... |
| - | General Fusion Invited to Ottawa to Address Canada’s Future Energy Needs | Burnaby, BC (November 28, 2016) — On Tuesday, November 29, General Fusion will address the House of Commons Standing Committee on Natural Resources, as Members of Parliament review Canada’s energy sector.
Michael Delage, Vice President Tech... |
| - | Evolva reports preliminary, unaudited financial results for 2013 and announces launch of share placement | BUSINESS UPDATE |
| - | Sequana Medical signs agreement with Fresenius Medical Care | Zurich, SWITZERLAND – 16 April 2015. Sequana Medical, a Swiss-based medical device company, announced today that it has entered into an agreement with Fresenius Medical Care to commercialize its innovative alfapump system. |
| - | D3O raises £13m in expansion capital | April 7, 2015 -- D3O, the UK-based developer of smart materials, announced today that it has raised a total of £13 million in funding from its existing investor Entrepreneurs Fund and new investor Beringea, to support the further expansion ... |
| - | Optinose Debt Financing | YARDLEY, Pa., Jan. 2, 2018 — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it has entered into a $100 million debt financing agreemen... |
| - | vasopharm Closes Series F Financing Round | The proceeds of this round will be used primarily for the preparation of a Phase III clinical study of the company’s lead compound VAS203, an allosteric nitric oxide synthase inhibitor under development for the treatment of traumatic brain ... |
| - | Sequana Medical's new DirectLink technology improves the care of patients | Zurich, SWITZERLAND – 1 December 2014. Technological advances in Sequana Medical’s alfapump system will allow patients and their doctors to better manage the distressing symptoms of refractory ascites, a condition in which fluid builds up i... |
| - | Evolva reaches milestone in BASF collaboration | Evolva has produced a yeast strain that achieves a fermentation yield that significantly exceeds the project requirement. Based on this achievement, BASF has made a low six-digit Swiss Franc milestone payment to Evolva. |
| - | Evolva reaches second milestone in Roquette collaboration | About Evolva |
| - | vasopharm Announces Last Patient Last Visit in NOSTRA III Traumatic Brain Injury Clinical Trial | Würzburg, Germany – vasopharm GmbH has announced that the Last Patient Last Visit (LPLV) in its phase 3 NOSTRA III clinical trial occurred on June 17, 2020. The company remains on schedule to deliver headline data in Q4 2020. |
| - | Heliocentris secures Japanese contract, rolls out in Myanmar | Berlin, 17 July 2015 - Heliocentris Energy Solutions AG which is listed in the Prime Standard of the Frankfurt Stock Exchange, has again received a major order in Asia and is announcing the roll-out to supply and install further turnkey hyb... |
| - | Patrick Dunne appointed as Chairman of D3O | D3O sells and licenses a range of unique patented smart materials and is a market leader in protective wear and shock absorbing materials. It supplies leading brands in the footwear, electronics, sport, motorcycle, industrial workwear, law ... |
| - | Emotion AI Company Realeyes Raises $12.4M Round To Fund Expansion Into Asia | June 6, 2019—Realeyes, whose emotion AI-powered products help brands such as Coca-Cola, Expedia and AT&T, maximise the effectiveness of their marketing campaigns, today announces a $12.4M (€11M) funding round.The investment is led by cu... |
| - | Astronaut and White House Energy and Climate Change Advisor Join General Fusion Advisory Council | BURNABY, British Columbia—(June 23, 2014)— General Fusion, a leader in developing fusion energy, has assembled a world-class Advisory Council that includes veteran Astronaut Mark Kelly and Carol M. Browner, a key figure in two US administra... |
| - | Evolva updates financial guidance | For 2013, Evolva maintains its expectation of a significant increase in revenues from the level achieved in 2012, and now guides that these are expected to be in the CHF 10-13 million range. |
| - | Sequana Medical receives Breakthrough Device designation from the FDA for its alfapump | Ghent, BELGIUM – 29 January 2019 – Sequana Medical receives Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for the alfapump® for the treatment of liver recurrent or refractory ascites. |
| - | Cargill and Evolva move into pilot scale ahead of schedule for fermentation-based steviol glycosides | Earlier this year, Cargill and Evolva entered into an agreement to jointly develop and commercialize fermentation-based steviol glycosides. Steviol glycosides are the compounds responsible for the sweet taste of stevia plant leaves. |
| - | Future Mobile digital public safety communications for Brandenburg: FutureE and adKor secure power supply with fuel cell systems | Upon completion, 53 of the 117 locations will be equipped with Jupiter fuel cell systems by FutureE. The innovative Jupiter systems provide emergency power and ensure the operation of the base stations around the clock — even in the event o... |
| - | Final Patient Completes Prosonix’ Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | PSX1002 is a novel, drug-only suspension formulation of the long-acting muscarinic antagonist (LAMA), glycopyrronium bromide (GB), which is in development as a potential ‘best-in-class’ orally inhaled monotherapy for chronic obstructive pul... |
| - | Exosect granted new patents | Winchester, UK – Exosect Ltd, a leading provider of enabling technologies, has been granted a patent in the UK and Canada for improved seed flowability and for improved methods of sowing seeds for dust drift reduction, using its proprietary... |
| - | OptiNose Announces Positive Results of COMPASS | YARDLEY, PA, June 10, 2014— OptiNose today announced that the COMPASS trial, a head-to-head comparison of the investigational treatment AVP-825 to sumatriptan tablets, currently the most widely used prescription medication for migraine, met... |
| - | The Ocean Cleanup secures full funding for prototype | THE OCEAN CLEANUP SECURES FULL FUNDING FOR PROTOTYPE
By: The Ocean Cleanup Team
Boskalis and the Government of the Netherlands main sponsors of €1.5 million test
THE HAGUE, June 8, 2016 – The Ocean Cleanup, the Dutch foundation developing a... |
| - | Optinose New Drug Application Submitted for Migraine Treatment Using OptiNose Technology | The NDA submission is based on a series of laboratory and clinical studies conducted by OptiNose in the U.S. and Europe, including comparative bioavailability and phase II and phase III efficacy studies in patients with migraine. The NDA fo... |
| - | Longer lasting plasma a milestone in General Fusion’s development plans | Vancouver, Canada – General Fusion has revealed that one of the most critical and complex areas of its research and development – plasma injector technology – has now reached the minimum performance levels required for a larger scale, integ... |
| - | Lifeline Scientific wins new contracts | Lifeline Scientific (AIM: LSIC), the transplantation technology company, announces a key account win in North America and further adoption in Europe and the Middle East, which combined are expected to contribute in excess of US$1.2m in annu... |
| - | General Fusion Appoints New Executives | VANCOUVER, CANADA – Clean energy leader General Fusion is enhancing the company’s design engineering capabilities and strategic partnerships with new leadership from veteran energy industry experts. The move comes as the company begins to t... |